Blog
What is the value of including dyads in pharmaceutical market research?
Dyadic interviews, in which two participants are interviewed together, are becoming more popular in qualitative research, but are much less discussed in the methodological literature than individual and focus groups. For a couple of years, however, e-Projection have used dyadic interviews as a research method and learned the strengths and the potential pitfalls associated with […]
Focus Group with e-Projection: We ensure your satisfaction at every step towards generating insights
Focus Group is one of the critical components of market research. On the basis of our research experience in Japan, e-Projection believes that our focus group research can provide creative solutions to our clients, adopting a constructive approach to designing the discussion which addresses the core of an issue, and steering the discussion in the […]
Another Year, Another Chapter for e-Projection
January used to be one of the most exciting times for the biotech industry, kicking off another new year with new perspectives and goals, and meeting with our best friends in San Francisco during the JP Morgan Healthcare Conference. This didn’t happen for a while, because of the pandemic. This year, for the first time […]
e-Projection is going to BIOTECH SHOWCASE 2023!
e-Projection will be attending the BIOTECH SHOWCASE 2023! This is an extraordinary opportunity for us to discuss about your strategy to expand your business globally!! Biotech Showcase is back in person! For the upcoming Biotech Showcase 2023 will be delivered in San Francisco in-person January 9–11, 2023. We will be in San Francisco finally this […]
e-Projection provides a high quality KOL interview service
KOL interviews can be a great method to gain an expert insight in to, for example, an evolving therapeutic landscape, unmet needs or a new therapy class. However, in order to obtain rich insights, it would be necessarily that KOLs are recruited and conducted to a high standard. We are here to help you to […]
Come & join our team at Biopharma America
e-Projection is attending 2022 BioPharm America virtual! We will put you in touch with Japanese healthcare industry, and help you to enter the Japanese market. Discuss your business challenges with us to get the best possible & innovative solutions to optimize your strategies and drive business growth in the Japanese market. If your company has […]
e-Projection talked at USC Comparative International Healthcare Systems course
Thank you USC Healthcare Decision Analysis & Biopharmaceutical Marketing for the opportunity to participate in this fantastic course, Comparative International Healthcare Systems! During this lecture, our CEO Tosh Nagate discussed with the attendees about the pharmaceutical industry in Japan and the general aspects of the pharmaceutical market. He also talked in-depth about the most important aspects of the pharmaceutical industry […]
Thanks for meeting with e-Projection at BIO2022
We had an amazing time talking about the future of biotech and networking with great people at BIO2022.The BIO International Convention is the major US convention bringing together representatives of the Pharma and Biotech Industry. This year more than 13,000 participants from more than 3,800 companies met at the San Diego Convention Center for 4 […]
Chuikyo approved listing of 14 Drugs on May 25
A total of 14 drugs will newly join Japan’s NHI price list on May 25. Chugai’s Vabysmo (faricimab), the first bispecific antibody in ophthalmology, for neovascular age-related macular degeneration and diabetic macular edema, is carrying the highest peak sales outlook among them, at 32 billion yen. Bayer’s non-steroidal selective mineralocorticoid receptor antagonist, Kerendia (Finelenone) also […]
Looking forward to meeting old and new contacts at Bio in San Diego
e-Projection will be participating in Bio International Convention ! Meet with us at BIO 2022 in San Diego, June 13-16 ! This is the most important event to promote us as an ideal partner for all seeking opportunity in Japan. And face-to face partnering opportunities are essential to progress in biotech, encouraging us to expand […]
